Rapp-Hodgkin syndrome and SHFM1 patients: Delineating the p63-Dlx5/Dlx6 pathway

Gene

Volumn 497, Issue 2, 2012, Pages 292-297

  Vera Carbonell, Ascensión ^a   Moya Quiles, María Rosa ^a   Ballesta Martínez, María ^a   López González, Vanesa ^a   Bafallíu, Juan Antonio ^a   Guillén Navarro, Encarna ^a   López Expósito, Isabel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Array CGH analysis; P63 mutation analysis; Rapp Hodgkin syndrome; Split hand foot malformation

Indexed keywords

PROTEIN P63; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR DLX6; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; CHROMOSOME 7Q; CHROMOSOME DELETION; CRANIOFACIAL MALFORMATION; ECTRODACTYLY; EXON; GENE CONTROL; GENE MUTATION; GROWTH RETARDATION; HUMAN; INFANT; MALE; MISSENSE MUTATION; NEWBORN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; RAPP HODGKIN SYNDROME; SYNDACTYLY;

ADOLESCENT; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; CLEFT LIP; CLEFT PALATE; CRANIOFACIAL ABNORMALITIES; ECTODERMAL DYSPLASIA; GENETIC DISEASES, X-LINKED; HOMEODOMAIN PROTEINS; HUMANS; INFANT; LIMB DEFORMITIES, CONGENITAL; MALE; MUTATION, MISSENSE; PROTEASOME ENDOPEPTIDASE COMPLEX; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84858276188     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.088     Document Type: Article

References (39)

1. Bertola D.R., Kim C.A., Albano L.M., Scheffer H., Meijer R., van Bokhoven H. Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder. Clin. Genet. 2004, 66:79-80.
2. Brown K.K., et al. Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35). Hum. Genet. 2010, 127:19-31.
3. Celli J., et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999, 99:143-153.
4. Crackower M.A., et al. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum. Mol. Genet. 1996, 5:571-579.
5. Di Constanzo A., et al. Homeodomain protein Dlx3 induces phosphorilation-dependent p63 degradation. Cell Cycle 2009, 8:1185-1195.
6. Dohn M., Zhang S., Chen X. p63α and δNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001, 20:3193-3205.
7. Duijf P.H.G., van Bokhoven H., Brunner H.G. Pathogenesis of split-hand/split-foot malformation. Hum. Mol. Genet. 2003, 12:R51-R60.
8. Elliott A.M., Evans J.A., Chudley A.E. Split hand foot malformation (SHFM). Clin. Genet. 2005, 68:501-505.
9. Elliott A.M., Evans J.A. Genotype-phenotype correlations in mapped split hand foot malformations (SHFM) patients. Am. J. Med. Genet. Part A 2006, 140A:1419-1427.
10. Ferrari D., et al. The expression pattern of the Distal-less homeobox-containing gene Dlx-5 in the developing chick limb bud suggests its involvement in apical ectodermal ridge activity, pattern formation, and cartilage differentiation. Mech. Dev. 1995, 52:257-264.
11. Ghioni P., Bolognese F., Duijf P.H.G., van Bokhoven H., Mantovani R., Guerrini L. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol. 2002, 22:8659-8668.
12. Haberlandt E., et al. Split hand/split foot malformation associated with sensorineural deafness, inner and middle ear malformation, hypodontia, congenital vertical talus, and deletion of eight microsatellite markers in 7q21.1-q21.3. J. Med. Genet. 2001, 38:405-409.
13. Helton E.S., Zhang J., Chen X. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63. Oncogene 2008, 27:2843-2850.
14. Jamora C., DasGupta R., Kocieniewski P., Fuchs E. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 2003, 422:317-322.
15. King K.E., et al. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis 2006, 27:53-63.
16. Kouwenhoven E.N., et al. Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet. 2010, 6:e1001065.
17. Leoyklang P., Siriwan P., Shotelersuk V. A mutation of the p63 gene in non-syndromic cleft lip. J. Med. Genet. 2006, 43:e28.
18. Lo Iacono N., et al. Regulation of Dlx5 and Dlx6 gene expresión by p63 is involved in EEC and SHFM congenital limb defects. Development 2008, 135:1377-1388.
19. McGrath J.A., et al. Hay-Wells syndrome is caused by heterozygous missense mutations in the Sam domain of p63. Hum. Mol. Genet. 2001, 10:221-229.
20. Mills A., Zhenh B., Wang X., Vogel H., Roop D., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398:708-713.
21. Moretti F., et al. A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J. Clin. Invest. 2010, 120:1570-1577.
22. Murray-Zmijewski F., Lane D.P., Bourdon J.C. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 2006, 13:92-972.
23. Nylander K., et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol. 2002, 198:417-427.
24. Rinne T., Brunner H.G., van Bokhoven H. p63-associated disorders. Cell Cycle 2007, 6:262-268.
25. Rinne T., et al. A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. Hum. Mol. Genet. 2008, 17:1968-1977.
26. Rinne T., Bolat E., Meijer R., Scheffer H., van Bokhoven H. Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC). Am. J. Med. Genet. Part A 2009, 149A:1948-1951.
27. Robledo R.F., Rajan L., Li X., Lufkin T. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev. 2002, 16:1089-1101.
28. Saitsu H., et al. Characterization of the complex 7q21.3 rearrangement in a patient with bilateral split-foot malformation and hearing loss. Am. J. Med. Genet. Part A 2009, 149A:1224-1230.
29. Scherer S.W., et al. Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly. Hum. Mol. Genet. 1994, 3:1345-1354.
30. Scherer S.W., et al. Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am. J. Hum. Genet. 1994, 55:12-20.
31. Slavotinek A.M., Tanaka J., Winder A., Vargervik K., Haggstrom A., Bamshad M. Acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome: report of a child with phenotypic overlap with ulnar-mammary syndrome and a new mutation in TP63. Am. J. Med. Genet. 2005, 138A:146-149.
32. Sutton V.R., Plunkett K., Dang D.X., Lewis R.A., Bree A.F., Bacino C.A. Craniofacial and anthropometric phenotype in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (Hay-Wells syndrome) in a cohort of 17 patients. Am. J. Med. Genet. Part A 2009, 149A:1916-1921.
33. van Bokhoven H., et al. p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformations suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 2001, 69:481-492.
34. van Bokhoven H., Brunner H.G. Splitting p63. Am. J. Hum. Genet. 2002, 71:1-13.
35. van Silfhout A.T., et al. Split hand/foot malformation due to chromosome 7q aberrations (SHFM1): additional support for functional haploinsufficiency as the causative mechanism. Eur. J. Hum. Genet. 2009, 17:1432-1438.
36. van Zelst-Stams W.A.G., van Steensel M.A.M. A novel TP63 mutation in family with ADULT syndrome presenting with eczema and hypothelia. Am. J. Med. Genet. 2009, 149A:1558-1560.
37. Wieland I., Muschke P., Jakubiczka S., Volleth M., Freigang B., Wieacker P.F. Refinement of the deletion in 7q21.3 associated with split hand/foot malformation type 1 and Mondini dysplasia. J. Med. Genet. 2004, 41:e54.
38. Yang A., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating death-inducing, and dominant-negative activities. Mol. Cell 1998, 2:305-316.
39. Yang A., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398:714-718.